Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction

In heart failure with preserved ejection fraction (HFpEF), natriuretic peptide (NP) levels are frequently lower. In several trials, the outcome differed between patients with low and high NP levels. This suggests that NP could be used to identify distinct stages of left ventricular (LV) remodeling a...

Full description

Bibliographic Details
Main Authors:	Elisa Dal Canto, Marielle Scheffer, Kirsten Kortekaas, Annet Driessen-Waaijer, Walter J. Paulus, Loek van Heerebeek
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Biomedicines
Subjects:	heart failure heart failure with preserved ejection fraction natriuretic peptides echocardiography cardiac magnetic resonance fibrosis
Online Access:	https://www.mdpi.com/2227-9059/11/3/867

Similar Items

Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction
by: Ulrika Löfström, et al.
Published: (2019-08-01)

The role of the diastolic stress echocardiographic test in the diagnosis of heart failure with preserved left ventricular ejection fraction
by: Bošković Nikola, et al.
Published: (2023-01-01)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
by: Mariëlle Scheffer, et al.
Published: (2020-12-01)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
by: Sharon Remmelzwaal, et al.
Published: (2020-10-01)

Predictive Role of Diastolic Echocardiographic Findings in the Outcome of Heart Failure with Preserved Ejection Fraction
by: Farveh Vakilian, et al.
Published: (2016-01-01)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
by: Arno A. van de Bovenkamp, et al.
Published: (2021-09-01)

Clinical Usefulness of Speckle-Tracking Echocardiography in Patients with Heart Failure with Preserved Ejection Fraction
by: Yixia Lin, et al.
Published: (2023-09-01)

Highest Obesity Category Associated With Largest Decrease in N‐Terminal Pro‐B‐Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction
by: Joban Vaishnav, et al.
Published: (2020-08-01)

Amino-Terminal Pro-Brain Natriuretic Peptid in Prediction of Left Ventricular Ejection Fraction
by: Mugdim Bajrić, et al.
Published: (2008-08-01)

The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients
by: Amer N. Kadri, et al.
Published: (2018-08-01)

Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus and its Association with Age, Gender, Duration and Glycosylated Haemoglobin: A Cross-sectional Study
by: Sawan Kumar Shukla, et al.
Published: (2023-04-01)

Heart failure with preserved ejection fraction – onset
by: Branimir Kanazirev
Published: (2021-07-01)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.

How to Use Natriuretic Peptides in Patients with Heart Failure with Non-Reduced Ejection Fraction?
by: Ahmet Çelik, et al.
Published: (2023-05-01)

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
by: Tetsuro Tsujimoto, et al.
Published: (2020-12-01)

Heart failure with preserved ejection fraction – new elements of evidence in the field of pathophysiology and new treatment options
by: Branimir Kanazirev
Published: (2021-07-01)

Association of ambient temperature and acute heart failure with preserved and reduced ejection fraction
by: Takahiro Jimba, et al.
Published: (2022-10-01)

Left Ventricular Strain in Heart Failure with Preserved Ejection Fraction
by: Madhu Shukla, et al.
Published: (2023-01-01)

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
by: Ajmer Singh, et al.
Published: (2018-01-01)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
by: Chiara Borrelli, et al.
Published: (2019-09-01)

Heart failure with preserved ejection fraction: insights from recent clinical researches
by: Mi-Na Kim, et al.
Published: (2020-05-01)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
by: Tin‐Kwang Lin, et al.
Published: (2019-06-01)

Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction
by: Xinxin Zhang, et al.
Published: (2021-12-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
by: Barry A. Borlaug, MD, et al.
Published: (2016-01-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction
by: Guoju Dong
Published: (2023-09-01)

Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
by: Akito Nakagawa, et al.
Published: (2022-08-01)

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
by: John Gierula, et al.
Published: (2022-10-01)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
by: Djawid Hashemi, et al.
Published: (2020-06-01)

Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction
by: Liam Gaziano, et al.
Published: (2021-12-01)

Baseline Longitudinal Strain Predicts Recovery of Left Ventricular Ejection Fraction in Hospitalized Patients With Nonischemic Cardiomyopathy
by: Stanley A. Swat, et al.
Published: (2018-10-01)

Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love—and Maybe, Redemption
by: Milton Packer
Published: (2024-04-01)

Heart failure with preserved ejection fraction—Out with the old and out with the new?
by: Luis Tolento Cortes, et al.
Published: (2022-07-01)

Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction
by: Dmitry Abramov, et al.
Published: (2021-06-01)

Prognostic significance of resting cardiac power to left ventricular mass and E/e’ ratio in heart failure with preserved ejection fraction
by: Cong Chen, et al.
Published: (2022-08-01)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
by: Luca Branca, et al.
Published: (2020-04-01)

Late ventricular potentials in chronic heart failure patients with preserved ejection fraction
by: A. G. Dushina, et al.
Published: (2017-06-01)

Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression
by: George E. Louridas, et al.
Published: (2016-09-01)